Department of Orthopedics - Spinal Surgery, Nanfang Hospital, Southern Medical University, 1838 Guangzhou North Avenue, Guangzhou, 510515, China.
Department of Orthopedics - Traumatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
J Nanobiotechnology. 2024 Jul 5;22(1):396. doi: 10.1186/s12951-024-02666-3.
Failed skin wound healing, through delayed wound healing or wound dehiscence, is a global public health issue that imposes significant burdens on individuals and society. Although the application of growth factor is an effective method to improve the pace and quality of wound healing, the clinically approved factors are limited. Parathyroid hormone (PTH) demonstrates promising results in wound healing by promoting collagen deposition and cell migration, but its application is limited by potentially inhibitory effects when administered continuously and locally. Through partially replacing and repeating the amino acid domains of PTH(1-34), we previously designed a novel PTH analog, PTH(3-34)(29-34) or MY-1, and found that it avoided the inhibitory effects of PTH while retaining its positive functions. To evaluate its role in wound healing, MY-1 was encapsulated in liposomes and incorporated into the methacryloyl gelatin (GelMA) hydrogel, through which an injectable nanocomposite hydrogel (GelMA-MY@Lipo, or GML) was developed. In vitro studies revealed that the GML had similar properties in terms of the appearance, microstructure, functional groups, swelling, and degradation capacities as the GelMA hydrogel. In vitro drug release testing showed a relatively more sustainable release of MY-1, which was still detectable in vivo 9 days post-application. When the GML was topically applied to the wound areas of rat models, wound closure as well as tensile strength were improved. Further studies showed that the effects of GML on wound repair and tensile strength were closely related to the promotion of fibroblast migration to the wound area through the controlled release of MY-1. Mechanically, MY-1 enhanced fibroblast migration by activating PI3K/AKT signaling and its downstream molecule, Rac1, by which it increased fibroblast aggregation in the early stage and resulting in denser collagen deposition at a later time. Overall, these findings demonstrated that the nanocomposite hydrogel system promoted skin wound healing and increased tensile strength, thus offering new potential in the treatment of wound healing.
皮肤创伤愈合失败,表现为延迟愈合或伤口裂开,是一个全球性的公共健康问题,给个人和社会带来了巨大的负担。虽然生长因子的应用是改善创伤愈合速度和质量的有效方法,但临床批准的因子有限。甲状旁腺激素(PTH)通过促进胶原蛋白沉积和细胞迁移显示出在伤口愈合方面有很好的效果,但由于连续和局部给药时可能具有抑制作用,其应用受到限制。通过部分替代和重复 PTH(1-34)的氨基酸结构域,我们之前设计了一种新型 PTH 类似物,PTH(3-34)(29-34)或 MY-1,并发现它避免了 PTH 的抑制作用,同时保留了其积极功能。为了评估其在伤口愈合中的作用,将 MY-1 包裹在脂质体中并整合到甲基丙烯酰化明胶(GelMA)水凝胶中,由此开发了一种可注射的纳米复合水凝胶(GelMA-MY@Lipo,或 GML)。体外研究表明,GML 在外观、微观结构、官能团、溶胀和降解能力方面与 GelMA 水凝胶相似。体外药物释放试验表明,MY-1 的释放相对更可持续,在应用后 9 天仍可在体内检测到。当 GML 局部应用于大鼠模型的伤口区域时,伤口闭合和拉伸强度都得到了改善。进一步的研究表明,GML 对伤口修复和拉伸强度的影响与通过控制 MY-1 的释放促进成纤维细胞迁移到伤口区域密切相关。从机械上讲,MY-1 通过激活 PI3K/AKT 信号及其下游分子 Rac1 来增强成纤维细胞的迁移,从而在早期增加成纤维细胞的聚集,并在后期导致更密集的胶原蛋白沉积。总的来说,这些发现表明,纳米复合水凝胶系统促进了皮肤伤口愈合并增加了拉伸强度,从而为伤口愈合治疗提供了新的潜力。